Earningsreport

Q1/2023 3/31/2023 EPS -0.180 ZacksConsensus -0.140 ActVsEst (0.040) - Miss

Pieris Pharmaceuticals, Inc.  (PIRS) 
NASDAQ:AMEX Investor Relations: ir.pieris.com